Back

Atrial fibrillation re-ablation: a comparative analysis of the efficacy of initial PVI procedures

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Invasive treatment of atrial fibrillation Catheter Ablation of Arrhythmias EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Daniel Filipe Inacio Cazeiro

Hospital Santa Maria, Lisbon (Portugal)

6 More presentations in this session

Presentation thumbnail
Outcomes of patients undergoing catheter ablation to treat atrial fibrillation using zero-fluoroscopy vs conventional approach.
Doctor D. Hincapie (Boston, US)
Abstract Slides Video
Presentation thumbnail
A prospective randomized clinical comparison of catheter ablation of atrial fibrillation using the CENTAURI PEF system and standard radiofrequency ablation
Doctor Z. Starek (Brno, CZ)
Abstract Slides Video
Presentation thumbnail
Visualizable vs. non-visualizable sheaths for atrial fibrillation ablation procedures: a systematic review and meta-analysis
Doctor D. Torma (Pecs, HU)
Abstract Slides Video
Presentation thumbnail
Panoramic atrial mapping offers advantages in the treatment of persistent atrial fibrillation compared with standard pulmonary vein isolation
Doctor R. Gagyi (Szeged, HU)
Abstract Slides Video
Presentation thumbnail
Long-term outcomes of patients treated with pulsed field ablation under the first-in-human clinical trials with prospective invasive remap
Doctor I. Sikiric (Split, HR)
Abstract Slides Video

Access the full session

Session thumbnail
Invasive treatment of atrial fibrillation

The Event

Event poster

EHRA 2025

30 March - 1 April 2025
You may be interested in
thumbnail
Congress Presentation
Advancements in ablation technology lead to improved durability and outcome of pulmonary vein isolation using radiofrequency energy
thumbnail
Congress Presentation
Pulsed-field ablation versus radiofrequency ablation in patients undergoing repeat catheter ablation for atrial fibrillation
thumbnail
Congress Presentation
Strategies for recurrent atrial fibrillation in patients despite durable pulmonary vein isolation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources